Literature DB >> 18240919

Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa.

Dima Suki1, Hiba Abouassi, Akash J Patel, Raymond Sawaya, Jeffrey S Weinberg, Morris D Groves.   

Abstract

OBJECT: The authors tested the hypothesis that patients with metastatic posterior fossa lesions (MPFLs) treated with resection have a higher risk of leptomeningeal disease (LMD) than those with MPFLs treated with stereotactic radiosurgery (SRS).
METHODS: Between 1993 and 2004, 379 patients with MPFLs were treated with resection or SRS at The University of Texas M. D. Anderson Cancer Center. The authors' primary study outcome was the incidence of LMD, as diagnosed with cerebrospinal fluid cytological analysis and/or neuroimaging.
RESULTS: Resection was performed in 260 patients, whereas 119 patients underwent SRS. The median patient age was 56 years, 51% of patients were male, and 93% had a Karnofsky Performance Scale score>or=70. The most common primary cancers were those of the lung, breast, and kidney, as well as melanoma. Leptomeningeal dissemination of cancer occurred in 33 patients: 26 in the resection group and 7 in the SRS group (resection group: rate ratio [RR] 2.06, 95% confidence interval [CI] 0.89-4.75, p=0.09). Piecemeal tumor resection (137 cases) was associated with a significantly higher risk of LMD than en bloc resection (123 cases; RR 3.4, 95% CI 1.43-8.12, p=0.006) or SRS (RR 3.37, 95% CI 1.41-8.04, p=0.006), and there was no significant difference in the risk for LMD between en bloc resection and SRS (en bloc resection: RR 0.98, 95% CI 0.34-2.81, p=0.98). The multivariate RR and significance associated with piecemeal resection, however, were consistent, with a strong effect (RR 2.45, 95% CI 1.19-5.02, p=0.02) and no indication of biases associated with tumor size, location, or cystic/necrotic appearance.
CONCLUSIONS: There is an increased risk of LMD after piecemeal resection of an MPFL. This increase, although clinically and statistically significant, is not as alarming as previously reported and is absent when en bloc removal is achieved. Further assessment of the role of resection in a controlled prospective setting is warranted.

Entities:  

Mesh:

Year:  2008        PMID: 18240919     DOI: 10.3171/JNS/2008/108/2/0248

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  45 in total

Review 1.  The impact of cerebral metastases growth pattern on neurosurgical treatment.

Authors:  Marcel A Kamp; Philipp J Slotty; Jan F Cornelius; Hans-Jakob Steiger; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2016-07-09       Impact factor: 3.042

2.  Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.

Authors:  Hideyuki Arita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Minako Sumi; Soichiro Shibui
Journal:  J Neurooncol       Date:  2013-10-25       Impact factor: 4.130

3.  Melanoma leptomeningeal dissemination following frontoparietal metastasis surgery: Case report and review of the literature.

Authors:  María Sereno Moyano; Gerardo Gutiérrez-Gutiérrez; Isabel Rodríguez-Esteban; Gemma Sánchez Crespo; Enrique Casado
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

4.  Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report).

Authors:  Astrid Dalhaug; Ellinor Haukland; Carsten Nieder
Journal:  World J Surg Oncol       Date:  2010-05-05       Impact factor: 2.754

5.  Commentary: The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis.

Authors:  Michael Zhang; Gordon Li
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-08-28       Impact factor: 2.703

Review 6.  Current Treatment Options for Breast Cancer Brain Metastases.

Authors:  Arrvind Raghunath; Kunal Desai; Manmeet S Ahluwalia
Journal:  Curr Treat Options Oncol       Date:  2019-02-15

Review 7.  Biology and therapy of neoplastic meningitis.

Authors:  Aaron G Mammoser; Morris D Groves
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

8.  Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.

Authors:  Johannes Knipps; Igor Fischer; Lisa M Neumann; Marion Rapp; Maxine Dibué-Adjei; Christiane Freiin von Saß; Jan-Malte Placke; Hendrik-Jan Mijderwijk; Hans-Jakob Steiger; Michael Sabel; Jan-Frederick Cornelius; Marcel A Kamp
Journal:  Clin Exp Metastasis       Date:  2019-08-02       Impact factor: 5.150

9.  Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.

Authors:  Fusako Waki; Masashi Ando; Atsuo Takashima; Kan Yonemori; Hiroshi Nokihara; Mototaka Miyake; Ukihide Tateishi; Koji Tsuta; Yasuhiro Shimada; Yasuhiro Fujiwara; Tomohide Tamura
Journal:  J Neurooncol       Date:  2008-11-29       Impact factor: 4.130

Review 10.  Management of brain metastases: the indispensable role of surgery.

Authors:  George Al-Shamy; Raymond Sawaya
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.